Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bromberg

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 26, 2024
ALSUntangled #75: Portable neuromodulation stimulator therapyLaurel Officer, Carmel Armon, Paul Barkhaus, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centresChristoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 4, 2013
ALS Untangled No. 20: the Deanna protocol, Christina Fournier, Bedlack Bedlack, et al.
JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 26, 2024
ALSUntangled #75: Portable neuromodulation stimulator therapyLaurel Officer, Carmel Armon, Paul Barkhaus, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centresChristoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 4, 2013
ALS Untangled No. 20: the Deanna protocol, Christina Fournier, Bedlack Bedlack, et al.
JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 4